Table 2.
Resistance profiles of ESBL-producing E. coli from well water and pit latrine wastewater.
| Antibiotics | Prevalence of resistance isolates, number (column%) | |
|---|---|---|
| Well water (n = 23) | Wastewater (n = 40) | |
| Ampicillin (AMP) | 23 (100) | 40 (100) |
| Piperacillin (PRL) | 18 (78.3) | 28 (70.0) |
| Amoxicillin/clavulanic acid (AMC) | 13 (56.5) | 11 (32.5) |
| Cephalothin (CF) | 23 (100) | 40 (100) |
| Cefuroxime (CXM) | 22 (95.6) | 39 (97.5) |
| Ceftazidime (CAZ) | 6 (26.1) | 18 (45.0) |
| Ceftriaxone (CRO) | 9 (39.1) | 20 (50.0) |
| Cefepime (CPM) | 3 (13.0) | 3 (7.5) |
| Imipenem (IPM) | 0 (0) | 0 (0) |
| Meropenem (MEC) | 0 (0) | 0 (0) |
| Amikacin (AMK) | 0 (0) | 4 (10.0) |
| Gentamicin (GM) | 7 (30.4) | 25 (62.5) |
| Nalidixic acid (NA) | 13 (56.5) | 27 (67.5) |
| Ciprofloxacin (CIP) | 10 (43.8) | 29 (72.5) |
| Tetracycline (TE) | 18 (78.3) | 23 (57.5) |
| Chloramphenicol (C) | 7 (30.4) | 15 (37.5) |